Viewing Study NCT06126718


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:57 AM
Study NCT ID: NCT06126718
Status: COMPLETED
Last Update Posted: 2025-06-24
First Post: 2023-11-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects
Sponsor: BioRay Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module